Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Proto Labs (PRLB) Financials

Proto Labs logo
$48.22 +0.52 (+1.09%)
Closing price 03:59 PM Eastern
Extended Trading
$48.26 +0.03 (+0.07%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Proto Labs

Annual Income Statements for Proto Labs

This table shows Proto Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 42 47 43 52 77 64 51 33 -103 17 17
Consolidated Net Income / (Loss)		 42 47 43 52 77 64 51 33 -103 17 17
Net Income / (Loss) Continuing Operations		 42 47 43 52 77 64 51 33 -103 17 17
Total Pre-Tax Income 		61 68 64 74 92 81 63 40 -98 28 25
Total Operating Income		 61 67 62 72 89 80 60 40 -98 28 20
Total Gross Profit		 128 154 167 194 239 235 218 223 215 222 223
Total Revenue		 210 264 298 344 446 459 434 488 488 504 501
Operating Revenue		 210 264 298 344 446 459 434 488 488 504 501
Total Cost of Revenue		 81 110 131 151 207 223 217 265 273 282 278
Operating Cost of Revenue		 81 110 131 151 207 223 217 265 273 282 278
Total Operating Expenses		 68 87 105 122 150 155 158 182 313 194 203
Selling, General & Admin Expense		 22 30 37 41 53 50 52 56 68 66 64
Marketing Expense		 29 39 46 57 69 73 69 82 83 88 92
Research & Development Expense		 17 18 22 24 29 33 37 44 38 40 41
Impairment Charge		 - - - - - - 0.00 0.00 118 0.00 0.00
Restructuring Charge		 - - - - - - - - 6.92 0.22 5.59
Total Other Income / (Expense), net		 0.00 0.71 2.45 2.21 2.76 1.34 3.11 -0.16 0.11 -0.22 4.76
Other Income / (Expense), net		 0.00 0.71 2.45 2.21 2.76 1.34 3.11 -0.16 0.11 -0.22 4.76
Income Tax Expense		 19 21 22 23 15 18 12 6.81 5.59 11 8.08
Basic Earnings per Share		 $1.62 $1.79 $1.62 $1.94 $2.84 $2.37 $1.90 $1.21 ($3.77) $0.66 $0.66
Weighted Average Basic Shares Outstanding		 25.69M 26.01M 26.37M 26.65M 26.98M 26.87M 26.74M 27.62M 27.41M 26.19M 25.10M
Diluted Earnings per Share		 $1.60 $1.77 $1.61 $1.93 $2.81 $2.35 $1.89 $1.21 ($3.77) $0.66 $0.66
Weighted Average Diluted Shares Outstanding		 26.10M 26.32M 26.56M 26.85M 27.28M 27.05M 26.90M 27.65M 27.41M 26.22M 25.21M
Weighted Average Basic & Diluted Shares Outstanding		 25.70M 26M 26.40M 26.70M 27M 26.79M 27.60M 27.47M 26.68M 25.72M 24.23M

Quarterly Income Statements for Proto Labs

This table shows Proto Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 -115 2.66 -0.38 7.95 6.99 5.27 4.54 7.19 -0.40 3.60 4.43
Consolidated Net Income / (Loss)		 -115 2.66 -0.38 7.95 6.99 5.27 4.54 7.19 -0.40 3.60 4.43
Net Income / (Loss) Continuing Operations		 -115 2.66 -0.38 7.95 6.99 5.27 4.54 7.19 -0.40 3.60 4.43
Total Pre-Tax Income 		-117 5.04 2.24 11 9.94 7.73 7.36 9.87 -0.28 5.99 6.67
Total Operating Income		 -117 3.75 5.61 10 8.40 6.83 6.00 8.58 -1.50 4.53 4.97
Total Gross Profit		 49 54 53 59 56 57 57 57 52 56 60
Total Revenue		 116 126 122 131 125 128 126 126 122 126 135
Operating Revenue		 116 126 122 131 125 128 126 126 122 126 135
Total Cost of Revenue		 67 72 69 71 69 70 69 68 70 71 75
Operating Cost of Revenue		 67 72 69 71 69 70 69 68 70 71 75
Total Operating Expenses		 166 50 48 49 47 51 51 49 53 51 55
Selling, General & Admin Expense		 18 17 16 17 16 16 17 16 15 17 19
Marketing Expense		 21 22 22 22 22 23 23 23 23 24 25
Research & Development Expense		 8.91 11 9.87 10 9.49 11 11 9.77 9.70 11 11
Other Operating Expenses / (Income)		 - 0.07 0.10 0.02 - 0.00 0.00 0.00 - -0.04 0.15
Total Other Income / (Expense), net		 0.43 1.29 -3.37 0.32 1.54 0.90 1.36 1.29 1.21 1.45 1.71
Other Income / (Expense), net		 0.43 1.29 -3.37 0.32 1.54 0.90 1.36 1.29 1.21 1.45 1.71
Income Tax Expense		 -1.64 2.38 2.62 2.78 2.95 2.46 2.82 2.68 0.12 2.39 2.25
Basic Earnings per Share		 ($4.19) $0.10 ($0.01) $0.31 $0.26 $0.21 $0.18 $0.29 ($0.02) $0.15 $0.19
Weighted Average Basic Shares Outstanding		 27.41M 26.58M 26.21M 26.02M 26.19M 25.62M 25.31M 24.98M 25.10M 24.14M 23.90M
Diluted Earnings per Share		 ($4.19) $0.10 ($0.01) $0.31 $0.26 $0.20 $0.18 $0.29 ($0.01) $0.15 $0.18
Weighted Average Diluted Shares Outstanding		 27.41M 26.61M 26.21M 26.03M 26.22M 25.78M 25.37M 25.02M 25.21M 24.44M 24.10M
Weighted Average Basic & Diluted Shares Outstanding		 26.68M 26.20M 26.10M 25.79M 25.72M 25.32M 25.15M 24.51M 24.23M 23.77M 23.87M

Annual Cash Flow Statements for Proto Labs

This table details how cash moves in and out of Proto Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 0.29 4.32 21 -32 48 40 2.38 -62 -9.37 27 5.28
Net Cash From Operating Activities		 57 64 77 82 123 116 107 55 62 73 78
Net Cash From Continuing Operating Activities		 57 64 77 82 123 116 107 55 62 73 78
Net Income / (Loss) Continuing Operations		 42 47 43 52 77 64 51 33 -103 17 17
Consolidated Net Income / (Loss)		 42 47 43 52 77 64 51 33 -103 17 17
Depreciation Expense		 11 14 17 18 27 31 33 40 39 38 36
Non-Cash Adjustments To Reconcile Net Income		 0.34 5.74 5.69 8.92 9.64 11 15 19 137 20 20
Changes in Operating Assets and Liabilities, net		 2.58 -3.52 10 1.52 9.58 10 8.76 -38 -11 -1.93 5.82
Net Cash From Investing Activities		 -63 -64 -61 -124 -63 -44 -95 -95 -43 -4.55 -14
Net Cash From Continuing Investing Activities		 -63 -64 -61 -124 -63 -44 -95 -95 -43 -4.55 -14
Purchase of Property, Plant & Equipment		 -44 -44 -34 -33 -87 -62 -47 -34 -22 -28 -9.17
Purchase of Investments		 -60 -66 -89 -29 -42 -50 -116 -16 -47 -1.00 -25
Sale of Property, Plant & Equipment		 - - - - - - 0.00 0.00 4.11 0.70 0.03
Sale and/or Maturity of Investments		 74 52 62 48 65 68 68 83 21 24 21
Net Cash From Financing Activities		 7.04 4.70 5.32 9.19 -10 -32 -11 -22 -28 -42 -59
Net Cash From Continuing Financing Activities		 7.04 4.70 5.32 9.19 -10 -32 -11 -22 -28 -42 -59
Repayment of Debt		 -1.05 -0.15 0.00 0.00 -5.00 0.00 -0.15 -0.56 -0.53 -0.31 -0.30
Repurchase of Common Equity		 - 0.00 0.00 -4.41 -12 -34 -15 -23 -30 -44 -60
Issuance of Common Equity		 4.82 6.25 5.72 8.60 8.94 4.39 7.56 5.86 3.95 3.84 4.02
Other Financing Activities, net		 4.47 - - 0.00 -2.14 -2.49 -3.44 -4.23 -1.68 -1.44 -2.00
Effect of Exchange Rate Changes		 -0.46 -0.88 -0.92 0.95 - 0.05 - -0.05 -0.44 0.37 -0.42
Cash Interest Paid		 0.02 0.01 0.00 0.02 0.04 0.01 0.02 0.03 0.10 1.06 0.14
Cash Income Taxes Paid		 12 20 9.80 19 9.97 4.00 5.65 7.58 19 16 14

Quarterly Cash Flow Statements for Proto Labs

This table details how cash moves in and out of Proto Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents		 -2.80 5.49 4.44 17 0.29 9.01 3.35 -8.28 1.20 -6.38 7.69
Net Cash From Operating Activities		 11 23 9.29 24 17 21 14 25 17 18 11
Net Cash From Continuing Operating Activities		 11 23 9.29 24 17 21 14 25 17 18 11
Net Income / (Loss) Continuing Operations		 -115 2.66 -0.38 7.95 6.99 5.27 4.54 7.19 -0.40 3.60 4.43
Consolidated Net Income / (Loss)		 -115 2.66 -0.38 7.95 6.99 5.27 4.54 7.19 -0.40 3.60 4.43
Depreciation Expense		 9.44 9.39 9.50 9.33 9.32 9.10 8.97 8.91 8.82 8.69 8.57
Non-Cash Adjustments To Reconcile Net Income		 122 3.98 7.43 4.66 4.37 4.26 4.25 4.46 6.63 4.22 4.49
Changes in Operating Assets and Liabilities, net		 -6.05 6.55 -7.26 2.23 -3.45 2.70 -3.32 4.20 2.24 1.87 -6.91
Net Cash From Investing Activities		 0.27 4.38 3.43 2.06 -14 4.42 -0.75 -14 -2.90 -2.91 -0.64
Net Cash From Continuing Investing Activities		 0.27 4.38 3.43 2.06 -14 4.42 -0.75 -14 -2.90 -2.91 -0.64
Purchase of Property, Plant & Equipment		 -5.27 -3.44 -3.39 -3.11 -18 -2.59 -4.20 -1.56 -0.83 -1.26 -1.47
Purchase of Investments		 -1.00 - - - -1.00 0.00 - - -6.98 -6.55 -4.50
Sale and/or Maturity of Investments		 5.66 7.63 6.39 5.10 4.75 6.98 3.44 5.29 4.92 4.91 5.33
Net Cash From Financing Activities		 -15 -22 -8.06 -9.07 -3.12 -17 -10 -19 -13 -22 -3.24
Net Cash From Continuing Financing Activities		 -15 -22 -8.06 -9.07 -3.12 -17 -10 -19 -13 -22 -3.24
Repayment of Debt		 -0.11 -0.08 -0.08 -0.07 -0.07 -0.07 -0.07 -0.07 -0.08 -0.08 -0.08
Repurchase of Common Equity		 -17 -21 -8.95 -8.99 -4.90 -16 -11 -19 -14 -21 -3.09
Issuance of Common Equity		 1.64 - - - - 0.00 - - - 0.29 1.79
Other Financing Activities, net		 -0.07 -0.40 0.96 -0.01 -1.99 -0.53 0.71 - -2.17 -1.25 -1.87
Effect of Exchange Rate Changes		 1.54 0.13 -0.21 -0.16 0.61 -0.12 -0.05 0.41 -0.65 0.08 0.99

Annual Balance Sheets for Proto Labs

This table presents Proto Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 287 361 414 519 619 674 744 929 802 772 744
Total Current Assets		 108 138 158 165 215 236 242 183 187 201 195
Cash & Equivalents		 43 48 69 37 85 125 128 66 57 84 89
Short-Term Investments		 31 33 39 57 47 35 34 12 24 19 14
Accounts Receivable		 24 36 34 52 59 57 58 80 76 73 67
Inventories, net		 6.19 9.77 9.31 11 10 10 11 13 14 14 12
Prepaid Expenses		 3.41 5.22 5.70 6.27 8.57 8.23 11 11 13 9.12 10
Current Deferred & Refundable Income Taxes		 0.00 6.03 0.45 1.83 5.76 0.00 0.54 1.32 4.04 2.23 2.91
Plant, Property, & Equipment, net		 92 125 139 166 228 264 283 280 258 254 227
Total Noncurrent Assets		 88 98 117 187 176 174 220 465 358 318 321
Long-Term Investments		 54 65 84 37 24 13 59 14 26 8.02 18
Noncurrent Note & Lease Receivables		 - - - - 0.00 0.00 2.40 1.90 18 0.96 0.69
Goodwill		 29 29 29 129 129 129 129 401 274 274 274
Intangible Assets		 4.08 3.34 2.66 19 20 17 14 38 31 26 21
Other Noncurrent Operating Assets		 0.23 0.52 0.93 2.67 3.44 14 15 9.90 8.62 9.48 7.52
Total Liabilities & Shareholders' Equity		 287 361 414 519 619 674 744 929 802 772 744
Total Liabilities		 21 33 34 58 77 88 100 100 105 77 73
Total Current Liabilities		 19 26 23 44 53 48 50 55 72 50 53
Accounts Payable		 7.88 14 11 16 17 17 18 25 17 16 16
Accrued Expenses		 2.72 2.63 4.44 8.41 17 11 16 12 22 17 20
Current Employee Benefit Liabilities		 6.07 9.99 7.67 12 18 15 12 14 13 15 17
Other Current Liabilities		 - - - - 0.00 3.34 3.82 3.85 19 1.88 1.60
Total Noncurrent Liabilities		 2.73 7.13 11 14 25 40 50 45 33 27 20
Noncurrent Deferred & Payable Income Tax Liabilities		 1.36 4.24 7.00 6.97 20 26 34 36 26 19 14
Other Noncurrent Operating Liabilities		 1.36 2.89 3.98 4.62 4.59 14 16 9.30 6.62 8.64 6.53
Total Equity & Noncontrolling Interests		 266 328 380 461 541 586 644 828 698 695 670
Total Preferred & Common Equity		 266 328 380 461 541 586 644 828 698 695 670
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 266 328 380 461 541 586 644 828 698 695 670
Common Stock		 181 199 214 242 259 268 285 469 474 467 454
Retained Earnings		 87 134 177 225 291 325 363 377 258 256 244
Accumulated Other Comprehensive Income / (Loss)		 -2.93 -5.21 -11 -5.23 -8.49 -7.02 -3.42 -17 -34 -28 -28

Quarterly Balance Sheets for Proto Labs

This table presents Proto Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2022 Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025
Period end date 6/30/2022 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025
Total Assets		 919 907 791 777 784 770 758 754 737 743
Total Current Assets		 191 192 189 185 205 210 208 193 194 206
Cash & Equivalents		 55 59 62 66 83 93 96 88 83 90
Short-Term Investments		 24 25 23 20 19 17 17 13 14 13
Accounts Receivable		 82 81 78 75 78 78 71 69 74 78
Inventories, net		 15 15 14 14 14 13 12 12 13 13
Prepaid Expenses		 11 12 11 8.50 8.72 9.43 10 10 9.59 9.99
Current Deferred & Refundable Income Taxes		 2.63 0.76 0.82 0.87 0.89 0.64 1.40 0.67 0.86 1.16
Plant, Property, & Equipment, net		 261 260 254 249 243 248 244 238 221 216
Total Noncurrent Assets		 467 455 349 343 337 312 307 323 322 322
Long-Term Investments		 31 29 20 16 12 3.26 0.00 17 19 20
Noncurrent Note & Lease Receivables		 1.65 1.52 17 17 17 0.89 0.83 0.76 0.63 0.56
Goodwill		 390 384 274 274 274 274 274 274 274 274
Intangible Assets		 34 32 30 28 27 24 23 23 21 21
Other Noncurrent Operating Assets		 10 8.48 8.09 7.82 7.08 9.04 8.63 8.01 7.02 6.88
Total Liabilities & Shareholders' Equity		 919 907 791 777 784 770 758 754 737 743
Total Liabilities		 98 96 108 95 99 82 73 74 81 79
Total Current Liabilities		 59 61 78 66 75 58 51 54 62 62
Accounts Payable		 16 17 20 16 18 15 16 15 16 16
Accrued Expenses		 24 25 23 19 21 21 18 18 24 26
Current Employee Benefit Liabilities		 17 15 15 12 16 16 16 18 19 19
Other Current Liabilities		 2.58 3.26 19 18 18 1.85 1.84 1.76 1.44 1.30
Total Noncurrent Liabilities		 39 35 30 28 25 24 22 20 19 16
Noncurrent Deferred & Payable Income Tax Liabilities		 30 27 23 21 17 16 15 13 12 9.74
Other Noncurrent Operating Liabilities		 8.86 8.51 6.60 7.51 7.56 7.58 7.44 7.35 6.50 6.64
Total Equity & Noncontrolling Interests		 821 811 683 683 685 687 685 680 657 665
Total Preferred & Common Equity		 821 811 683 683 685 687 685 680 657 665
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 821 811 683 683 685 687 685 680 657 665
Common Stock		 476 477 465 465 464 463 461 454 447 450
Retained Earnings		 381 381 251 247 251 253 253 253 237 239
Accumulated Other Comprehensive Income / (Loss)		 -36 -47 -33 -29 -30 -29 -29 -27 -27 -25

Annual Metrics And Ratios for Proto Labs

This table displays calculated financial ratios and metrics derived from Proto Labs' official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 28.49% 26.02% 12.85% 15.58% 29.35% 2.95% -5.30% 12.36% 0.06% 3.17% -0.59%
EBITDA Growth		 20.74% 13.71% -0.41% 13.38% 26.40% -5.66% -14.74% -15.56% -172.46% 212.02% -7.64%
EBIT Growth		 17.36% 12.11% -5.36% 15.90% 23.13% -11.41% -22.47% -36.16% -343.57% 128.56% -11.73%
NOPAT Growth		 18.66% 10.55% -10.76% 22.32% 47.85% -15.72% -22.76% -30.71% -304.72% 125.30% -22.83%
Net Income Growth		 18.02% 11.72% -8.18% 21.24% 47.92% -16.89% -20.09% -34.39% -410.03% 116.64% -3.64%
EPS Growth		 17.65% 10.63% -9.04% 19.88% 45.60% -16.37% -19.57% -35.98% -411.57% 117.51% 0.00%
Operating Cash Flow Growth		 18.10% 12.04% 20.91% 5.48% 50.38% -5.59% -7.83% -48.36% 12.38% 18.03% 6.22%
Free Cash Flow Firm Growth		 -208.61% 105.02% 2,548.70% -371.50% 123.75% 57.51% 1.79% -851.94% 127.50% -68.83% 102.55%
Invested Capital Growth		 100.18% 32.52% 2.79% 79.09% 15.24% 6.75% 2.70% 74.02% -19.76% -1.12% -6.02%
Revenue Q/Q Growth		 6.09% 7.18% -0.47% 6.76% 4.35% -0.19% -1.51% 3.91% -1.61% 1.91% -0.65%
EBITDA Q/Q Growth		 2.73% 3.38% -1.52% 4.99% 3.90% -1.11% -7.28% 3.78% -181.19% 207.29% -15.05%
EBIT Q/Q Growth		 1.14% 3.80% -3.35% 6.07% 2.61% -2.64% -11.00% 3.56% -408.20% 128.32% -29.29%
NOPAT Q/Q Growth		 1.86% 3.13% -5.17% 10.14% 5.95% -4.24% -11.47% 9.40% -387.71% 125.46% -34.64%
Net Income Q/Q Growth		 1.68% 4.03% -5.78% 10.45% 7.01% -6.05% -9.93% 7.51% -540.02% 116.43% -30.83%
EPS Q/Q Growth		 1.27% 4.12% -5.85% 9.66% 6.84% -6.00% -10.00% 8.04% -538.37% 117.41% -29.03%
Operating Cash Flow Q/Q Growth		 6.84% 9.58% -4.27% 4.33% 14.13% -4.68% -6.70% -2.78% -16.76% 10.09% 0.08%
Free Cash Flow Firm Q/Q Growth		 7.20% -91.51% 191.18% -351.91% 121.96% 7.22% -3.39% 2.63% 9.79% -59.22% 72.65%
Invested Capital Q/Q Growth		 1.28% 10.82% -4.15% 65.86% 2.20% 0.75% -0.45% -0.89% -15.19% 2.54% -2.32%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 61.27% 58.46% 56.01% 56.27% 53.56% 51.29% 50.14% 45.62% 44.12% 44.06% 44.56%
EBITDA Margin		 34.92% 31.51% 27.81% 27.28% 26.66% 24.43% 21.99% 16.53% -11.97% 13.00% 12.07%
Operating Margin		 28.88% 25.43% 20.72% 20.97% 19.95% 17.41% 13.77% 8.27% -20.06% 5.59% 3.98%
EBIT Margin		 28.88% 25.69% 21.55% 21.61% 20.57% 17.70% 14.49% 8.23% -20.04% 5.55% 4.93%
Profit (Net Income) Margin		 19.87% 17.61% 14.33% 15.03% 17.19% 13.88% 11.71% 6.84% -21.18% 3.42% 3.31%
Tax Burden Percent		 68.78% 68.54% 66.50% 69.56% 83.56% 78.40% 80.81% 83.05% 105.71% 61.61% 67.25%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 31.22% 31.46% 33.50% 30.44% 16.44% 21.60% 19.19% 16.95% 0.00% 38.39% 32.75%
Return on Invested Capital (ROIC)		 40.43% 28.83% 22.26% 19.24% 20.60% 15.69% 11.58% 5.78% -10.33% 2.95% 2.36%
ROIC Less NNEP Spread (ROIC-NNEP)		 40.43% 28.47% 21.29% 18.28% 18.96% 15.05% 10.30% 5.86% 24.82% 3.07% -0.40%
Return on Net Nonoperating Assets (RNNOA)		 -22.98% -13.14% -10.18% -6.93% -5.32% -4.39% -3.31% -1.25% -3.23% -0.48% 0.07%
Return on Equity (ROE)		 17.45% 15.68% 12.07% 12.31% 15.28% 11.29% 8.27% 4.53% -13.56% 2.47% 2.43%
Cash Return on Invested Capital (CROIC)		 -26.32% 0.85% 19.51% -37.43% 6.44% 9.16% 8.91% -48.25% 11.59% 4.08% 8.57%
Operating Return on Assets (OROA)		 23.41% 20.94% 16.57% 15.96% 16.11% 12.56% 8.88% 4.80% -11.31% 3.55% 3.26%
Return on Assets (ROA)		 16.10% 14.35% 11.02% 11.10% 13.46% 9.85% 7.18% 3.99% -11.96% 2.19% 2.19%
Return on Common Equity (ROCE)		 17.45% 15.68% 12.07% 12.31% 15.28% 11.29% 8.27% 4.53% -13.56% 2.47% 2.43%
Return on Equity Simple (ROE_SIMPLE)		 15.68% 14.20% 11.24% 11.23% 14.14% 10.87% 7.89% 4.03% -14.83% 2.48% 2.48%
Net Operating Profit after Tax (NOPAT)		 42 46 41 50 74 63 48 34 -69 17 13
NOPAT Margin		 19.86% 17.43% 13.78% 14.58% 16.67% 13.65% 11.13% 6.86% -14.04% 3.44% 2.67%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.36% 0.96% 0.96% 1.64% 0.64% 1.27% -0.08% -35.16% -0.12% 2.76%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -9.83% 2.50% 2.00%
Cost of Revenue to Revenue		 38.74% 41.54% 43.99% 43.73% 46.44% 48.71% 49.86% 54.38% 55.88% 55.94% 55.44%
SG&A Expenses to Revenue		 10.56% 11.25% 12.30% 11.96% 11.78% 10.85% 11.91% 11.46% 13.83% 13.06% 12.84%
R&D to Revenue		 7.92% 6.95% 7.51% 6.84% 6.45% 7.13% 8.50% 9.06% 7.83% 7.97% 8.24%
Operating Expenses to Revenue		 32.38% 33.04% 35.29% 35.30% 33.61% 33.88% 36.37% 37.36% 64.18% 38.47% 40.59%
Earnings before Interest and Taxes (EBIT)		 61 68 64 74 92 81 63 40 -98 28 25
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 73 83 83 94 119 112 96 81 -58 65 60
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 5.09 3.57 5.95 5.64 4.64 6.37 1.71 0.99 1.44 1.43
Price to Tangible Book Value (P/TBV)		 0.00 5.64 3.90 8.75 7.77 6.18 8.19 3.63 1.76 2.54 2.56
Price to Revenue (P/Rev)		 0.00 6.31 4.55 7.97 6.85 5.92 9.45 2.90 1.42 1.99 1.91
Price to Earnings (P/E)		 0.00 35.82 31.78 53.01 39.87 42.69 80.68 42.45 0.00 58.34 57.74
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 2.79% 3.15% 1.89% 2.51% 2.34% 1.24% 2.36% 0.00% 1.71% 1.73%
Enterprise Value to Invested Capital (EV/IC)		 0.00 8.36 6.22 7.81 7.51 6.17 9.17 1.80 0.99 1.53 1.52
Enterprise Value to Revenue (EV/Rev)		 0.00 5.76 3.91 7.60 6.50 5.55 8.94 2.71 1.20 1.77 1.67
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 18.27 14.05 27.86 24.40 22.70 40.64 16.42 0.00 13.65 13.84
Enterprise Value to EBIT (EV/EBIT)		 0.00 22.41 18.13 35.18 31.62 31.33 61.69 32.97 0.00 31.98 33.93
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 33.04 28.35 52.12 39.01 40.63 80.30 39.54 0.00 51.51 62.52
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 23.73 15.03 32.03 23.57 21.92 36.30 23.98 9.44 12.20 10.76
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 1,119.01 32.35 0.00 124.84 69.58 104.34 0.00 7.61 37.27 17.24
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.57 -0.46 -0.48 -0.38 -0.28 -0.29 -0.32 -0.21 -0.13 -0.16 -0.17
Leverage Ratio		 1.08 1.09 1.10 1.11 1.13 1.15 1.15 1.14 1.13 1.13 1.11
Compound Leverage Factor		 1.08 1.09 1.10 1.11 1.13 1.15 1.15 1.14 1.13 1.13 1.11
Debt to Total Capital		 0.06% 0.00% 0.00% 1.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.05% 0.00% 0.00% 1.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 99.94% 100.00% 100.00% 98.93% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 -1.75 0.00 0.00 -1.34 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 -3.08 0.00 0.00 -2.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.00 32.19 25.89 30.65 25.82 20.64 26.52 9.90 4.80 9.29 9.31
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 5.75 5.25 6.74 3.77 4.08 4.97 4.82 3.34 2.61 4.04 3.66
Quick Ratio		 5.24 4.45 6.08 3.33 3.62 4.58 4.37 2.87 2.18 3.54 3.18
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -27 1.36 36 -98 23 37 37 -280 77 24 49
Operating Cash Flow to CapEx		 131.50% 144.48% 230.54% 250.49% 141.13% 186.49% 227.55% 161.48% 353.16% 267.26% 851.99%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.81 0.82 0.77 0.74 0.78 0.71 0.61 0.58 0.56 0.64 0.66
Accounts Receivable Turnover		 9.85 8.75 8.49 8.05 8.05 7.87 7.53 7.08 6.25 6.76 7.19
Inventory Turnover		 14.29 13.74 13.74 14.64 19.38 22.16 20.69 22.10 20.41 20.70 21.39
Fixed Asset Turnover		 2.84 2.43 2.25 2.25 2.26 1.87 1.59 1.73 1.82 1.97 2.08
Accounts Payable Turnover		 11.32 10.19 10.50 11.08 12.43 13.06 12.36 12.17 12.78 17.09 17.83
Days Sales Outstanding (DSO)		 37.05 41.70 42.97 45.33 45.32 46.39 48.45 51.57 58.40 53.99 50.77
Days Inventory Outstanding (DIO)		 25.54 26.56 26.56 24.93 18.84 16.47 17.64 16.52 17.88 17.63 17.06
Days Payable Outstanding (DPO)		 32.23 35.81 34.75 32.95 29.36 27.95 29.54 29.99 28.57 21.36 20.47
Cash Conversion Cycle (CCC)		 30.36 32.45 34.78 37.31 34.80 34.91 36.56 38.10 47.71 50.27 47.37
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 137 182 187 335 386 412 423 737 591 584 549
Invested Capital Turnover		 2.04 1.65 1.62 1.32 1.24 1.15 1.04 0.84 0.74 0.86 0.88
Increase / (Decrease) in Invested Capital		 69 45 5.08 148 51 26 11 313 -146 -6.63 -35
Enterprise Value (EV)		 0.00 1,521 1,165 2,618 2,898 2,544 3,883 1,325 586 894 837
Market Capitalization		 0.00 1,666 1,357 2,745 3,053 2,717 4,104 1,417 692 1,005 958
Book Value per Share		 $10.34 $12.52 $14.37 $17.31 $20.00 $21.89 $24.08 $30.03 $25.73 $26.96 $27.34
Tangible Book Value per Share		 $9.05 $11.29 $13.18 $11.77 $14.51 $16.43 $18.74 $14.13 $14.47 $15.35 $15.29
Total Capital		 266 328 380 466 541 586 644 828 698 695 670
Total Debt		 0.15 0.00 0.00 5.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -128 -146 -193 -126 -155 -174 -221 -92 -107 -111 -121
Capital Expenditures (CapEx)		 44 44 34 33 87 62 47 34 18 27 9.14
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 15 31 26 32 31 28 30 51 35 48 38
Debt-free Net Working Capital (DFNWC)		 89 112 134 126 163 189 192 129 115 151 142
Net Working Capital (NWC)		 89 112 134 121 163 189 192 129 115 151 142
Net Nonoperating Expense (NNE)		 -0.00 -0.49 -1.63 -1.54 -2.30 -1.05 -2.51 0.13 35 0.13 -3.20
Net Nonoperating Obligations (NNO)		 -128 -146 -193 -126 -155 -174 -221 -92 -107 -111 -121
Total Depreciation and Amortization (D&A)		 13 15 19 20 27 31 33 40 39 38 36
Debt-free, Cash-free Net Working Capital to Revenue		 7.26% 11.69% 8.75% 9.32% 6.92% 6.14% 6.92% 10.47% 7.14% 9.56% 7.68%
Debt-free Net Working Capital to Revenue		 42.58% 42.31% 45.08% 36.65% 36.50% 41.17% 44.14% 26.35% 23.54% 29.96% 28.27%
Net Working Capital to Revenue		 42.51% 42.31% 45.08% 35.20% 36.50% 41.17% 44.14% 26.35% 23.54% 29.96% 28.27%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.62 $1.79 $1.62 $1.94 $2.84 $2.37 $1.90 $1.21 ($3.77) $0.66 $0.66
Adjusted Weighted Average Basic Shares Outstanding		 25.69M 26.01M 26.37M 26.65M 26.98M 26.87M 26.74M 27.62M 27.41M 26.19M 25.10M
Adjusted Diluted Earnings per Share		 $1.60 $1.77 $1.61 $1.93 $2.81 $2.35 $1.89 $1.21 ($3.77) $0.66 $0.66
Adjusted Weighted Average Diluted Shares Outstanding		 26.10M 26.32M 26.56M 26.85M 27.28M 27.05M 26.90M 27.65M 27.41M 26.22M 25.21M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 25.87M 26.20M 26.53M 26.90M 26.98M 26.79M 27.60M 27.47M 26.68M 25.72M 24.23M
Normalized Net Operating Profit after Tax (NOPAT)		 42 46 41 50 74 63 48 34 19 17 17
Normalized NOPAT Margin		 19.86% 17.43% 13.78% 14.58% 16.67% 13.65% 11.13% 6.86% 3.86% 3.47% 3.42%
Pre Tax Income Margin		 28.88% 25.69% 21.55% 21.61% 20.57% 17.70% 14.49% 8.23% -20.04% 5.55% 4.93%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 2.88% 3.01% 0.94% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 2.88% 3.01% 0.94% 8.52% 15.97% 52.66% 28.87% 69.76% -28.67% 255.23% 363.27%

Quarterly Metrics And Ratios for Proto Labs

This table displays calculated financial ratios and metrics derived from Proto Labs' official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -6.45% 1.36% -3.65% 7.38% 8.17% 1.61% 2.75% -3.89% -2.64% -1.32% 7.51%
EBITDA Growth		 -562.54% -19.05% -23.02% 27.47% 117.95% 16.65% 39.17% -6.42% -55.63% -12.78% -6.66%
EBIT Growth		 -1,002.44% -33.61% -56.94% 77.91% 108.52% 53.32% 228.57% -8.08% -102.84% -22.53% -9.32%
NOPAT Growth		 -782.21% -62.65% -137.51% 94.54% 107.20% 135.31% 485.92% -19.00% -117.72% -41.47% -10.93%
Net Income Growth		 -1,066.12% -47.81% -114.98% 101.32% 106.07% 98.12% 1,285.38% -9.62% -105.78% -31.68% -2.49%
EPS Growth		 -1,052.27% -47.37% -111.11% 121.43% 106.21% 100.00% 1,900.00% -6.45% -103.85% -25.00% 0.00%
Operating Cash Flow Growth		 -54.32% 26.96% -29.93% 17.81% 63.84% -5.49% 55.49% 2.38% 0.38% -13.87% -26.72%
Free Cash Flow Firm Growth		 121.09% 2,322.14% 241.97% 168.20% -80.28% -94.14% -91.28% -89.68% 172.35% 320.72% 201.61%
Invested Capital Growth		 -19.76% -20.19% -18.39% -18.22% -1.12% -0.70% -1.31% -1.34% -6.02% -5.89% -5.38%
Revenue Q/Q Growth		 -5.02% 8.87% -2.86% 6.90% -4.33% 2.27% -1.77% -0.01% -3.08% 3.66% 7.02%
EBITDA Q/Q Growth		 -781.40% 113.45% -18.66% 70.98% -4.05% -12.59% -2.95% 14.97% -54.51% 71.85% 3.85%
EBIT Q/Q Growth		 -2,034.09% 104.32% -55.55% 379.24% -7.42% -22.26% -4.74% 34.08% -102.86% 2,222.34% 11.51%
NOPAT Q/Q Growth		 -2,167.01% 102.41% -148.47% 904.79% -23.48% -21.16% -20.51% 68.92% -116.74% 360.36% 20.97%
Net Income Q/Q Growth		 -3,012.30% 102.31% -114.40% 2,176.76% -12.12% -24.64% -13.82% 58.35% -105.62% 990.84% 23.01%
EPS Q/Q Growth		 -3,092.86% 102.39% -110.00% 3,200.00% -16.13% -23.08% -10.00% 61.11% -103.45% 1,600.00% 20.00%
Operating Cash Flow Q/Q Growth		 -48.77% 114.72% -58.86% 160.30% -28.75% 23.86% -32.31% 71.39% -30.14% 6.27% -42.41%
Free Cash Flow Firm Q/Q Growth		 26.55% 133.31% -12.51% 3.82% -90.69% -30.66% 30.10% 22.91% 145.62% 7.12% -6.73%
Invested Capital Q/Q Growth		 -15.19% -2.15% 0.26% -1.71% 2.54% -1.73% -0.36% -1.74% -2.32% -1.59% 0.18%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 42.05% 42.73% 43.45% 45.36% 44.63% 44.93% 45.01% 45.56% 42.68% 44.13% 44.26%
EBITDA Margin		 -92.78% 11.46% 9.60% 15.35% 15.40% 13.16% 13.00% 14.95% 7.02% 11.63% 11.29%
Operating Margin		 -101.32% 2.98% 4.59% 7.97% 6.71% 5.34% 4.78% 6.83% -1.23% 3.59% 3.68%
EBIT Margin		 -100.95% 4.00% 1.83% 8.21% 7.95% 6.04% 5.86% 7.86% -0.23% 4.74% 4.94%
Profit (Net Income) Margin		 -99.53% 2.11% -0.31% 6.09% 5.59% 4.12% 3.61% 5.72% -0.33% 2.85% 3.28%
Tax Burden Percent		 98.60% 52.77% -17.10% 74.09% 70.34% 68.19% 61.68% 72.85% 143.26% 60.13% 66.33%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 47.23% 117.10% 25.91% 29.66% 31.81% 38.32% 27.15% 0.00% 39.87% 33.67%
Return on Invested Capital (ROIC)		 -52.18% 1.18% -0.59% 4.61% 4.05% 3.19% 2.60% 4.43% -0.76% 1.93% 2.23%
ROIC Less NNEP Spread (ROIC-NNEP)		 -18.84% 0.54% -1.13% 4.40% 3.05% 2.63% 1.83% 3.62% -1.31% 1.17% 1.27%
Return on Net Nonoperating Assets (RNNOA)		 2.45% -0.08% 0.16% -0.67% -0.48% -0.42% -0.29% -0.62% 0.22% -0.20% -0.22%
Return on Equity (ROE)		 -49.73% 1.11% -0.43% 3.94% 3.57% 2.78% 2.32% 3.81% -0.54% 1.73% 2.01%
Cash Return on Invested Capital (CROIC)		 11.59% 11.48% 9.22% 9.28% 4.08% 4.21% 5.12% 4.97% 8.57% 8.13% 7.52%
Operating Return on Assets (OROA)		 -56.97% 2.27% 1.05% 4.80% 5.09% 3.92% 3.89% 5.15% -0.15% 3.14% 3.35%
Return on Assets (ROA)		 -56.17% 1.20% -0.18% 3.56% 3.58% 2.67% 2.40% 3.75% -0.22% 1.89% 2.22%
Return on Common Equity (ROCE)		 -49.73% 1.11% -0.43% 3.94% 3.57% 2.78% 2.32% 3.81% -0.54% 1.73% 2.01%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -15.50% -15.94% -15.31% 0.00% 2.89% 3.61% 3.53% 0.00% 2.27% 0.00%
Net Operating Profit after Tax (NOPAT)		 -82 1.98 -0.96 7.72 5.90 4.66 3.70 6.25 -1.05 2.72 3.30
NOPAT Margin		 -70.92% 1.57% -0.78% 5.90% 4.72% 3.64% 2.95% 4.98% -0.86% 2.16% 2.44%
Net Nonoperating Expense Percent (NNEP)		 -33.34% 0.64% 0.54% 0.21% 1.00% 0.56% 0.78% 0.81% 0.55% 0.76% 0.96%
Return On Investment Capital (ROIC_SIMPLE)		 -11.75% - - - 0.85% - - - -0.16% 0.41% 0.50%
Cost of Revenue to Revenue		 57.96% 57.27% 56.55% 54.64% 55.37% 55.07% 54.99% 54.44% 57.32% 55.87% 55.74%
SG&A Expenses to Revenue		 15.37% 13.37% 12.94% 13.05% 12.86% 12.76% 13.21% 12.94% 12.46% 13.35% 13.88%
R&D to Revenue		 7.70% 8.48% 8.07% 7.73% 7.59% 8.73% 8.49% 7.78% 7.97% 8.41% 8.27%
Operating Expenses to Revenue		 143.36% 39.75% 38.86% 37.39% 37.92% 39.60% 40.23% 38.73% 43.90% 40.54% 40.58%
Earnings before Interest and Taxes (EBIT)		 -117 5.04 2.24 11 9.94 7.73 7.36 9.87 -0.28 5.99 6.67
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -107 14 12 20 19 17 16 19 8.54 15 15
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.99 1.29 1.34 1.01 1.44 1.34 1.14 1.09 1.43 1.29 1.43
Price to Tangible Book Value (P/TBV)		 1.76 2.33 2.41 1.79 2.54 2.37 2.02 1.93 2.56 2.35 2.57
Price to Revenue (P/Rev)		 1.42 1.80 1.89 1.39 1.99 1.82 1.54 1.46 1.91 1.70 1.87
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 58.34 46.49 31.59 30.79 57.74 56.90 64.26
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 1.71% 2.15% 3.17% 3.25% 1.73% 1.76% 1.56%
Enterprise Value to Invested Capital (EV/IC)		 0.99 1.35 1.40 1.01 1.53 1.41 1.17 1.10 1.52 1.36 1.53
Enterprise Value to Revenue (EV/Rev)		 1.20 1.59 1.68 1.16 1.77 1.60 1.31 1.23 1.67 1.47 1.63
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 13.65 11.92 9.23 8.72 13.84 12.56 14.47
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 31.98 26.40 18.71 17.80 33.93 31.96 37.25
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 51.51 40.00 30.55 30.31 62.52 63.93 75.03
Enterprise Value to Operating Cash Flow (EV/OCF)		 9.44 11.66 12.93 8.62 12.20 11.23 8.67 7.99 10.76 9.79 11.67
Enterprise Value to Free Cash Flow (EV/FCFF)		 7.61 10.42 13.67 9.76 37.27 33.35 22.68 22.07 17.24 16.18 19.80
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.13 -0.14 -0.14 -0.15 -0.16 -0.16 -0.16 -0.17 -0.17 -0.17 -0.17
Leverage Ratio		 1.13 1.14 1.13 1.13 1.13 1.14 1.12 1.13 1.11 1.12 1.11
Compound Leverage Factor		 1.13 1.14 1.13 1.13 1.13 1.14 1.12 1.13 1.11 1.12 1.11
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 4.73 6.16 7.08 5.48 9.22 8.09 7.85 7.41 9.20 7.69 8.67
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.61 2.41 2.80 2.74 4.04 3.60 4.08 3.59 3.66 3.13 3.31
Quick Ratio		 2.18 2.07 2.44 2.43 3.54 3.21 3.61 3.16 3.18 2.75 2.91
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 64 148 130 135 13 8.69 11 14 34 37 34
Operating Cash Flow to CapEx		 239.47% 695.35% 313.92% 796.41% 94.79% 831.89% 344.78% 1,596.00% 2,083.61% 1,456.34% 720.98%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.56 0.57 0.57 0.58 0.64 0.65 0.66 0.66 0.66 0.66 0.68
Accounts Receivable Turnover		 6.25 5.99 6.16 6.22 6.76 6.51 6.98 6.82 7.19 6.58 6.83
Inventory Turnover		 20.41 19.41 18.82 19.68 20.70 20.68 21.01 21.14 21.39 21.35 22.25
Fixed Asset Turnover		 1.82 1.87 1.91 1.97 1.97 2.02 2.07 2.10 2.08 2.13 2.21
Accounts Payable Turnover		 12.78 14.81 17.21 16.06 17.09 15.96 17.30 16.83 17.83 17.61 18.03
Days Sales Outstanding (DSO)		 58.40 60.91 59.21 58.69 53.99 56.08 52.29 53.52 50.77 55.48 53.43
Days Inventory Outstanding (DIO)		 17.88 18.80 19.39 18.55 17.63 17.65 17.37 17.27 17.06 17.10 16.40
Days Payable Outstanding (DPO)		 28.57 24.65 21.21 22.72 21.36 22.87 21.09 21.68 20.47 20.72 20.24
Cash Conversion Cycle (CCC)		 47.71 55.07 57.39 54.52 50.27 50.86 48.57 49.10 47.37 51.85 49.59
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 591 578 580 570 584 574 572 562 549 541 541
Invested Capital Turnover		 0.74 0.75 0.75 0.78 0.86 0.88 0.88 0.89 0.88 0.90 0.91
Increase / (Decrease) in Invested Capital		 -146 -146 -131 -127 -6.63 -4.04 -7.61 -7.65 -35 -34 -31
Enterprise Value (EV)		 586 780 813 574 894 809 669 621 837 733 829
Market Capitalization		 692 884 916 689 1,005 922 782 739 958 849 952
Book Value per Share		 $25.73 $25.61 $26.05 $26.25 $26.96 $26.82 $27.07 $27.04 $27.34 $27.10 $27.96
Tangible Book Value per Share		 $14.47 $14.22 $14.52 $14.73 $15.35 $15.18 $15.32 $15.23 $15.29 $14.94 $15.57
Total Capital		 698 683 683 685 695 687 685 680 670 657 665
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -107 -105 -103 -115 -111 -113 -113 -118 -121 -116 -123
Capital Expenditures (CapEx)		 4.39 3.25 2.96 3.04 18 2.57 4.19 1.55 0.83 1.26 1.47
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 35 25 32 27 48 42 44 39 38 35 40
Debt-free Net Working Capital (DFNWC)		 115 110 119 130 151 152 157 139 142 132 143
Net Working Capital (NWC)		 115 110 119 130 151 152 157 139 142 132 143
Net Nonoperating Expense (NNE)		 33 -0.68 -0.58 -0.24 -1.09 -0.61 -0.84 -0.94 -0.64 -0.87 -1.13
Net Nonoperating Obligations (NNO)		 -107 -105 -103 -115 -111 -113 -113 -118 -121 -116 -123
Total Depreciation and Amortization (D&A)		 9.44 9.39 9.50 9.33 9.32 9.10 8.97 8.91 8.82 8.69 8.57
Debt-free, Cash-free Net Working Capital to Revenue		 7.14% 5.19% 6.69% 5.50% 9.56% 8.36% 8.59% 7.70% 7.68% 7.11% 7.89%
Debt-free Net Working Capital to Revenue		 23.54% 22.51% 24.50% 26.27% 29.96% 30.04% 30.76% 27.63% 28.27% 26.51% 28.18%
Net Working Capital to Revenue		 23.54% 22.51% 24.50% 26.27% 29.96% 30.04% 30.76% 27.63% 28.27% 26.51% 28.18%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($4.19) $0.10 ($0.01) $0.31 $0.26 $0.21 $0.18 $0.29 ($0.02) $0.15 $0.19
Adjusted Weighted Average Basic Shares Outstanding		 27.41M 26.58M 26.21M 26.02M 26.19M 25.62M 25.31M 24.98M 25.10M 24.14M 23.90M
Adjusted Diluted Earnings per Share		 ($4.19) $0.10 ($0.01) $0.31 $0.26 $0.20 $0.18 $0.29 ($0.01) $0.15 $0.18
Adjusted Weighted Average Diluted Shares Outstanding		 27.41M 26.61M 26.21M 26.03M 26.22M 25.78M 25.37M 25.02M 25.21M 24.44M 24.10M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 26.68M 26.20M 26.10M 25.79M 25.72M 25.32M 25.15M 24.51M 24.23M 23.77M 23.87M
Normalized Net Operating Profit after Tax (NOPAT)		 -82 1.98 3.93 7.72 5.90 4.66 3.70 6.25 -1.05 2.72 3.30
Normalized NOPAT Margin		 -70.92% 1.57% 3.21% 5.90% 4.72% 3.64% 2.95% 4.98% -0.86% 2.16% 2.44%
Pre Tax Income Margin		 -100.95% 4.00% 1.83% 8.21% 7.95% 6.04% 5.86% 7.86% -0.23% 4.74% 4.94%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -28.67% -47.95% -50.06% -53.07% 255.23% 195.90% 164.94% 212.01% 363.27% 436.58% 387.00%

Key Financial Trends

Proto Labs (NYSE: PRLB) has shown several noteworthy trends over the last four years through Q2 2025 across its income, cash flow, and balance sheet statements.

Positive trends:

  • Revenue Growth: Operating revenue increased steadily from about $115.6M in Q4 2022 to $135.1M in Q2 2025, indicating consistent top-line growth over multiple quarters.
  • Profit Improvement: Net income recovered from significant losses in late 2022 (e.g., -$115M in Q4 2022) to positive earnings of $4.43M in Q2 2025. Earnings per share improved from negative levels to $0.18 diluted EPS in Q2 2025.
  • Gross Profit Expansion: Gross profit has grown from around $48.6M in Q4 2022 to nearly $59.8M in Q2 2025, reflecting better cost control or pricing power.
  • Strong Operating Cash Flows: Cash flow from operating activities remains robust, with Q2 2025 showing $10.58M and consistent positive cash flow generation since early 2023.
  • Healthy Balance Sheet: Total equity increased from approximately $683M in early 2023 to $665M at Q2 2025 (noting some fluctuation), with reasonable liabilities that appear well-managed.
  • Consistent Depreciation: Depreciation expense remains steady, suggesting stable capital asset base supporting operations.

Neutral observations:

  • Investment Activities: Proto Labs has routinely invested in property, plant, equipment, and investments, with both purchases and sales/maturities affecting cash flows. The net effect shows moderate capital expenditures, supporting growth but also requiring monitoring.
  • Share Repurchases: The company has engaged in common stock repurchases across quarters, which may enhance shareholder value but also uses significant cash.
  • Fluctuating Marketing and R&D Expenses: Marketing and R&D expenses tend to fluctuate quarter to quarter, reflecting ongoing investments in growth and innovation but warranting attention to efficiency.

Negative factors:

  • Historical Losses in 2022: Large net losses in Q4 2022, primarily due to unusual costs or write-downs, resulted in a net loss of $115M that year-end, impacting past financial health.
  • Volatile Other Income / (Expense): Net other income/expense has shown fluctuations, including negative swings in some quarters, which could impact overall profitability unpredictably.

Summary: Overall, Proto Labs has shown a strong recovery from losses in late 2022, driven by steady revenue growth and improving profitability. The company maintains strong cash flow generation and a solid balance sheet, whereas investments in capex and share repurchases reflect ongoing strategic moves. Investors should watch for continued margin improvements and control over volatile expenses to assess future profitability sustainability.

08/21/25 03:14 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Proto Labs' Financials

When does Proto Labs' fiscal year end?

According to the most recent income statement we have on file, Proto Labs' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Proto Labs' net income changed over the last 10 years?

Proto Labs' net income appears to be on a downward trend, with a most recent value of $16.59 million in 2024, falling from $41.64 million in 2014. The previous period was $17.22 million in 2023. View Proto Labs' forecast to see where analysts expect Proto Labs to go next.

What is Proto Labs' operating income?
Proto Labs' total operating income in 2024 was $19.91 million, based on the following breakdown:
  • Total Gross Profit: $223.20 million
  • Total Operating Expenses: $203.29 million
How has Proto Labs' revenue changed over the last 10 years?

Over the last 10 years, Proto Labs' total revenue changed from $209.58 million in 2014 to $500.89 million in 2024, a change of 139.0%.

How much debt does Proto Labs have?

Proto Labs' total liabilities were at $73.36 million at the end of 2024, a 4.8% decrease from 2023, and a 241.3% increase since 2014.

How much cash does Proto Labs have?

In the past 10 years, Proto Labs' cash and equivalents has ranged from $36.71 million in 2017 to $127.60 million in 2020, and is currently $89.07 million as of their latest financial filing in 2024.

How has Proto Labs' book value per share changed over the last 10 years?

Over the last 10 years, Proto Labs' book value per share changed from 10.34 in 2014 to 27.34 in 2024, a change of 164.6%.


Related Companies

This page (NYSE:PRLB) was last updated on 8/21/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel